Jingwen Feng

机构：Tufts University, China Pharmaceutical University, Shenzhen University, Tianjin Huanhu Hospital, Water Technology (Australia), Children's Hospital of Zhejiang University, Stomatology Hospital, Jensen Hughes (United States), First Hospital of China Medical University, First Affiliated Hospital Zhejiang University, Shanghai Ocean University, Jining Medical University, Zhejiang University, China Medical University · ORCID：0000-0003-4501-8792

发表论文 95 篇 · 总被引 2076 次 · h-index 25

代表论文

• Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy (2024 · Advanced Materials · 被引 114)
• Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies (2025 · Biomedicines · 被引 58)
• Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis (2024 · Materials Today · 被引 56)
• Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis (2024 · Hepatology International · 被引 33)
• Effects of high-intensity intermittent exercise on glucose and lipid metabolism in type 2 diabetes patients: a systematic review and meta-analysis (2024 · Frontiers in Endocrinology · 被引 30)
• Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial (2025 · European Heart Journal · 被引 13)